Neurovascular Unit for Aged Patients With Geriatric Care and Evaluation of Factors Associated With Autonomy Loss

NCT07805694 | Not Yet Recruiting

• 1 other identifier: 25-5376
• Study Type: observational
• Target: 3,500
• Locations: 1 country
• Sites: 1

Brief Summary

There are few neurovascular units (short stay and MRS (medical and rehabilitation service)) dedicated to the care of older people after a stroke in France and around the world. The geriatric medicine department at Charpennes Hospital developed this unit more than 20 years ago, giving it unique experience and expertise acquired over many years. However, to date, the profiles of patients included in these units and the factors associated with loss of independence and the outcomes of older patients hospitalized in neurovascular units for older adults remain unknown. In this context, the NUAGE study aims to describe the population cared for in this unit and analyze the factors associated with patient outcomes.

Conditions

Stroke

Keywords

Neurovascular hospital unit; Comorbidities; Autonomy

Outcome Measures

Primary Outcomes (1)

• Describe the characteristics of hospitalized patients and their outcomes in the geriatric neurovascular unit at Hôpital des Charpennes (short stay and MRS).

  The following data will be collected to describe the characteristics of the study population : Age (years) Gender (F/M) IMC (kg/m²) Smoking/alcohol consumption Comorbidities (Charlson score) Presence/Absence of Hypertension, DiabetesTreatment Type of stroke (ischemic or hemorrhagic) + Artery involved Complications related to treatment (falls, spastic pain, swallowing disorders, malnutrition, infections, bedsores, epilepsy) Biological parameters (cholesterol (g/L), albumin (g/L)) Cognitive and cardiovascular assessments related to stroke assessment (cardiac ultrasound, arterial Doppler ultrasound, radiocinema) National Institutes of Health Stroke Scale (NIHSS) Modified Rankin Scale (mRS) Measure of functional independence (MIF) Type of discharge (death, institutionalization, return home)

  Data will be collected on the day of admission (day 1 of the patient's hospitalization) and on the day of his/her discharge from the neurovascular unit.

Study Arms (1)

Patients hospitalized in the neurovascular unit for older adults at Charpennes Hospital, HCL.

Patients over 65 years of age hospitalized for short-term medical-surgical care in geriatrics or MRS (medical and rehabilitation service) in the neurovascular unit for older adults at Charpennes Hospital, HCL Villeurbanne

Other: Not applicable- observational study

Interventions

Not applicable- observational study OTHER

not applicable - observational study

Patients hospitalized in the neurovascular unit for older adults at Charpennes Hospital, HCL.

Eligibility Criteria

• Age: 65 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients over 65 years of age hospitalized for short-term medical-surgical care in geriatrics or MRS (medical and rehabilitation service) in the neurovascular unit for the elderly (4AC) at Charpennes Hospital, HCL Villeurbanne

You may qualify if:

• \- Patients over 65 years of age
• Hospitalized for short-term medical-surgical care in geriatrics or MRS (medical and rehabilitation service) in the neurovascular unit for the elderly (4AC) at Charpennes Hospital, HCL Villeurbanne

You may not qualify if:

• \- Patients, relatives/trusted individuals, legal representatives who object to the research

Sponsors & Collaborators

• Hospices Civils de Lyon: lead

Study Sites (1)

Hôpital des Charpennes (Hospices Civils de Lyon)

Villeurbanne, 69100, France

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Vascular Diseases; Cardiovascular Diseases

Central Study Contacts

Marie M BRETON, MD

CONTACT

04.72.43.21.18; marie.breton@chu-lyon.fr

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 11, 2026
• First Posted: September 4, 2026
• Study Start (Estimated): December 15, 2026
• Primary Completion (Estimated): December 31, 2030
• Study Completion (Estimated): December 31, 2031
• Last Updated: September 4, 2026

Record last verified: 2026-06

Locations

FR (1)